Axa S.A. Seagen Inc. Transaction History

Axa S.A.

  • $32.8 Billion
  • Q1 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$191.51 - $216.16 $269,454 - $304,137
1,407 Added 2.07%
69,247 $14.7 Million
Q2 2023

Aug 14, 2023
SELL
$187.64 - $206.25 $8.28 Million - $9.11 Million
-44,151 Reduced 39.42%
67,840 $13.1 Million
Q1 2023

May 15, 2023
SELL
$127.59 - $203.08 $78,467 - $124,894
-615 Reduced 0.55%
111,991 $22.7 Million
Q4 2022

Feb 14, 2023
BUY
$117.37 - $139.17 $637,671 - $756,110
5,433 Added 5.07%
112,606 $14.5 Million
Q3 2022

Feb 14, 2023
BUY
$135.27 - $180.11 $57,895 - $77,087
428 Added 0.4%
107,173 $14.7 Million
Q3 2022

Nov 14, 2022
BUY
$135.27 - $180.11 $57,895 - $77,087
428 Added 0.4%
107,173 $14.7 Million
Q2 2022

Feb 14, 2023
SELL
$108.81 - $179.33 $5.33 Million - $8.78 Million
-48,944 Reduced 31.44%
106,745 $18.9 Million
Q2 2022

Aug 15, 2022
SELL
$108.81 - $179.33 $5.33 Million - $8.78 Million
-48,944 Reduced 31.44%
106,745 $18.9 Million
Q1 2022

Feb 14, 2023
BUY
$119.61 - $157.85 $5.8 Million - $7.66 Million
48,516 Added 45.27%
155,689 $22.4 Million
Q1 2022

May 13, 2022
BUY
$119.61 - $157.85 $119 - $157
1 Added 0.0%
155,689 $22.4 Million
Q4 2021

Feb 14, 2022
SELL
$142.57 - $190.86 $21.1 Million - $28.3 Million
-148,209 Reduced 48.77%
155,688 $24.1 Million
Q3 2021

Nov 15, 2021
BUY
$142.45 - $169.82 $22.1 Million - $26.3 Million
155,058 Added 104.18%
303,897 $51.6 Million
Q2 2021

Aug 13, 2021
SELL
$135.08 - $161.1 $1.55 Million - $1.85 Million
-11,511 Reduced 7.18%
148,839 $23.5 Million
Q1 2021

May 14, 2021
BUY
$137.51 - $190.8 $472,759 - $655,970
3,438 Added 2.19%
160,350 $22.3 Million
Q4 2020

Feb 12, 2021
BUY
$164.63 - $211.93 $25.8 Million - $33.3 Million
156,912 New
156,912 $27.5 Million

Others Institutions Holding SGEN

# of Institutions
40
Shares Held
1.26M
Call Options Held
23K
Put Options Held
55.2K
View Full List

About Seagen Inc.

SGEN Quotes by TradingView
  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email